Prion Diseases: Current Understanding of Epidemiology and Pathogenesis, and Therapeutic Advances

ISSN： 1172-7047

Source： CNS Drugs, Vol.20, Iss.1, 2006-01, pp. : 15-28

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Advanced Glycation End Products: Association with the Pathogenesis of Diseases and the Current Therapeutic Advances

Current Clinical Pharmacology, Vol. 11, Iss. 2, 2016-08 ,pp. : 118-127

Bentham Science Publishers

Access to resources Recommend Favorite

Current Updates on Therapeutic Advances in the Management of Cardiovascular Diseases

Current Pharmaceutical Design, Vol. 22, Iss. 5, 2016-02 ,pp. : 566-571

Bentham Science Publishers

Access to resources Recommend Favorite

Recent Advances in Understanding the Pathogenesis of Polycystic Kidney Disease: Therapeutic Implications

By Cowley Jr B.D.

Drugs, Vol. 64, Iss. 12, 2004-01 ,pp. : 1285-1294

Adis International

Access to resources Recommend Favorite

Involvement of Trace Elements in the Pathogenesis of Prion Diseases

Current Pharmaceutical Biotechnology, Vol. 15, Iss. 11, 2014-11 ,pp. : 1049-1057

Bentham Science Publishers

Access to resources Recommend Favorite

Prion diseases: update on therapeutic patents (1999 – 2002)

By Larner Andrew J Doran Mark

Expert Opinion on Therapeutic Patents, Vol. 13, Iss. 1, 2003-01 ,pp. : 67-78

Informa Healthcare

Access to resources Recommend Favorite